The NLR family pyrin domain containing 3 inflammasome in the mechanism of electroacupuncture: Current status and future perspectives
Frontiers in Aging Neuroscience, 2022 · DOI: 10.3389/fnagi.2022.913881 · Published: October 19, 2022
Simple Explanation
Electroacupuncture is a widely used alternative medicine treatment, but its mechanism of action is not fully understood. The NLR family pyrin domain containing 3 (NLRP3) inflammasome is closely associated with Alzheimer’s disease, spinal cord injury, and other diseases and plays an important role in the diagnosis and treatment of human immune system diseases. Some scholars have found that the NLRP3 inflammasome is a part of the mechanism of action of electroacupuncture, which has attracted further attention.
Key Findings
- 1Electroacupuncture can alleviate diseases by targeting the NLRP3 inflammasome.
- 2Electroacupuncture reduces inflammation and symptoms by inhibiting NLRP3 inflammasome activation and the secretion of proinflammatory factors, such as IL-1β.
- 3The mechanism by which electroacupuncture targets the NLRP3 inflammasome in the treatment of diseases may involve the downregulation of NLRP3 inflammasome expression and inhibition of the inflammatory response.
Research Summary
Practical Implications
Clinical Practice
Electroacupuncture can be considered as a treatment option in a wide range of clinical practices, especially when drug intervention has large adverse reactions or the single treatment effect is not significant.
Further Research
Advanced technologies such as high-throughput sequencing and single-cell sequencing can be used to extract clinical samples for further mechanism research.
Protocol Optimization
Unify electroacupuncture treatment protocols in future studies to observe whether there is a difference in the effects of different experimental protocols on the expression of the NLRP3 inflammasome.
Study Limitations
- 1Existing studies focus on animal experiments, with limited clinical trials.
- 2Heterogeneity in electroacupuncture protocols (acupoints, frequency, duration) makes it difficult to draw definitive conclusions.
- 3The internal mechanism of action by which pathway to inhibit NLRP3 inflammasome activation or expression is not complete, and further research is needed.